INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of INDO US BIOTECH ?
| Year | Current Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
How is Current Liabilities of INDO US BIOTECH Trending?
| Years | Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Current Liabilities of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹214.0 Cr | 2.2% | -5.6% | -28.2% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,089.7 Cr | 2.5% | -10.8% | -22% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,667.3 Cr | 8.4% | 21% | -29.8% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,058.3 Cr | 19.4% | 13.8% | -12.5% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,018.1 Cr | 11% | 14.4% | -12.9% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹393.8 Cr | 7.2% | 19.6% | -20.2% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | 2.2% |
-5.6% |
-28.2% |
| SENSEX | 4.8% |
-4.2% |
0.8% |
You may also like the below Video Courses